TCG Lifesciences’ in vivo service provides validated platforms for regular screening as well as in-depth studies in the therapeutic areas of pain (with special focus on neuropathic pain), inflammation and CNS with a proven track record of supporting successful collaborations globally for the past 12 years. The development of platforms for oncology and anti-bacterial screens are in progress. The in vivo team, comprising experts in pharmacology and veterinary sciences, provide complete support from study design to final data analysis and reporting. The team also offers the flexibility of using available platforms for developing customized models efficiently to support the preclinical discovery program. The teams of in vivo scientists work in concert with the in vitro and bioanalytical teams to support more complex study designs like PK/PD correlation including biomarker analysis and to maximize the value of obtained research data.
The TCGLS animal house is equipped with state-of-the-art rodent holding and breeding facility governed by the Institutional Animal Ethics Committee (IAEC), a blanket import license is also in place for procurement of rodent strains from international sources as per project needs. The present facility has been further expanded for capacity enhancement and for AAALAC accreditation.
Efficacy Model Portfolio
Inflammation Acute inflammation
Mechanical & Thermal Nociception
List of state of the art equipment>>